CWC Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

CWC Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$870K	Sell	5,499 -131	-2%	-$17.7K	0.39%	64
2026 Q1	$719K	Sell	5,630 -61	-1%	-$7.62K	0.34%	70
2025 Q4	$694K	Sell	5,691 -16	-0.3%	-$1.83K	0.34%	70
2025 Q3	$572K	Buy	5,707 +157	+3%	+$14.1K	0.28%	82
2025 Q2	$460K	Buy	5,550 +183	+3%	+$14.6K	0.24%	88
2025 Q1	$435K	Buy	5,367 +1,919	+56%	+$172K	0.25%	86
2024 Q4	$311K	Buy	3,448 +67	+2%	+$6.49K	0.31%	87
2024 Q3	$334K	Buy	+3,381	New	+$332K	0.33%	82

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

CWC Advisors's XBI Position: Q2 2026 in Review

CWC Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 2.3% in Q2 2026, selling an estimated $17.7K and leaving 5,499 shares worth $870K. The position accounts for 0.39% of the portfolio, ranked #64.

CWC Advisors first reported a position in XBI in Q3 2024 and has held it in 8 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

CWC Advisors held 5,499 shares of State Street SPDR S&P Biotech ETF worth $870K as of Q2 2026.
CWC Advisors sold 131 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $17.7K.
State Street SPDR S&P Biotech ETF made up 0.39% of CWC Advisors's portfolio in Q2 2026, its #64 holding.
CWC Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2024 and has held it in 8 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on CWC Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.